WO2001040257A3 - Polypeptides cytokines et acides nucleiques - Google Patents

Polypeptides cytokines et acides nucleiques Download PDF

Info

Publication number
WO2001040257A3
WO2001040257A3 PCT/US2000/032664 US0032664W WO0140257A3 WO 2001040257 A3 WO2001040257 A3 WO 2001040257A3 US 0032664 W US0032664 W US 0032664W WO 0140257 A3 WO0140257 A3 WO 0140257A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acids
polypeptides
subunits
modified
acids encoding
Prior art date
Application number
PCT/US2000/032664
Other languages
English (en)
Other versions
WO2001040257A2 (fr
Inventor
Steven R Leong
Juha Punnonen
Original Assignee
Maxygen Inc
Steven R Leong
Juha Punnonen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Inc, Steven R Leong, Juha Punnonen filed Critical Maxygen Inc
Priority to JP2001541012A priority Critical patent/JP2003517305A/ja
Priority to CA002389262A priority patent/CA2389262A1/fr
Priority to EP00982327A priority patent/EP1244689A2/fr
Priority to AU19376/01A priority patent/AU1937601A/en
Publication of WO2001040257A2 publication Critical patent/WO2001040257A2/fr
Publication of WO2001040257A3 publication Critical patent/WO2001040257A3/fr
Priority to AU2006202896A priority patent/AU2006202896A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5434—IL-12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne de nouveaux polypeptides cytokines ainsi que les acides nucléiques codant pour eux. L'invention concerne également des compositions comprenant ces polypeptides et ces acides nucléiques, des cellules recombinées comprenant ces polypeptides et ces acides nucléiques, des méthodes de fabrication de ces polypeptides et de ces acides nucléiques, des anticorps dirigés contre ces polypeptides ainsi que des méthodes d'utilisation de ces polypeptides et de ces acides nucléiques. L'invention concerne en outre des systèmes intégrés comprenant les séquences de ces acides nucléiques ou de ces polypeptides.
PCT/US2000/032664 1999-12-02 2000-11-30 Polypeptides cytokines et acides nucleiques WO2001040257A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2001541012A JP2003517305A (ja) 1999-12-02 2000-11-30 改変ｉｌ−１２サブユニットおよびそれらをコードする核酸
CA002389262A CA2389262A1 (fr) 1999-12-02 2000-11-30 Polypeptides cytokines et acides nucleiques
EP00982327A EP1244689A2 (fr) 1999-12-02 2000-11-30 Polypeptides cytokines et acides nucleiques
AU19376/01A AU1937601A (en) 1999-12-02 2000-11-30 Cytokine polypeptides and nucleic acids
AU2006202896A AU2006202896A1 (en) 1999-12-02 2006-07-06 Cytokine polypeptides and nucleic acids

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16903599P 1999-12-02 1999-12-02
US60/169,035 1999-12-02
US09/725,324 2000-11-28
US09/725,324 US7115712B1 (en) 1999-12-02 2000-11-28 Cytokine polypeptides

Publications (2)

Publication Number Publication Date
WO2001040257A2 WO2001040257A2 (fr) 2001-06-07
WO2001040257A3 true WO2001040257A3 (fr) 2001-11-29

Family

ID=26864699

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/032664 WO2001040257A2 (fr) 1999-12-02 2000-11-30 Polypeptides cytokines et acides nucleiques

Country Status (5)

Country Link
US (2) US7115712B1 (fr)
EP (1) EP1244689A2 (fr)
JP (1) JP2003517305A (fr)
CA (1) CA2389262A1 (fr)
WO (1) WO2001040257A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090142855A1 (en) * 2005-06-30 2009-06-04 Wei Tang Polynucleotides and Polypeptides of the IL-12 Family of Cytokines
CN101351475B (zh) * 2005-12-30 2013-05-15 默克专利有限公司 具有提高的稳定性的白细胞介素12p40变体
CA2664423A1 (fr) 2006-09-22 2008-03-27 St. Jude Children's Research Hospital Modulation de l'activite regulatrice des lymphocytes t via l'interleukine 35
US20130183326A9 (en) 2009-11-20 2013-07-18 St. Jude Children's Research Hospital Methods and compositions for modulating the activity of the interleukin-35 receptor complex
GB202219855D0 (en) * 2022-12-30 2023-02-15 Univ Oxford Innovation Ltd Affinity capture reagents for mass spectrometry

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041368A2 (fr) * 1998-02-11 1999-08-19 Maxygen, Inc. Optimisation des proprietes immunomodulatrices des vaccins genetiques

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5866363A (en) 1985-08-28 1999-02-02 Pieczenik; George Method and means for sorting and identifying biological information
US5824469A (en) 1986-07-17 1998-10-20 University Of Washington Method for producing novel DNA sequences with biological activity
US5001065A (en) 1987-05-27 1991-03-19 Cetus Corporation Human cell line and triomas, antibodies, and transformants derived therefrom
US4948666A (en) * 1988-04-22 1990-08-14 Mobay Corporation Stain resistant polycarbonate panels
US5457038A (en) 1988-11-10 1995-10-10 Genetics Institute, Inc. Natural killer stimulatory factor
AU638430B2 (en) 1988-11-10 1993-07-01 Genetics Institute, Llc Natural killer stimulatory factor
US5811523A (en) 1988-11-10 1998-09-22 Trinchieri; Giorgio Antibodies to natural killer stimulatory factor
EP0790309B1 (fr) 1989-12-22 2007-07-25 F. Hoffmann-La Roche Ag Sous-unité de 40kD du facteur de maturation de lymphocyte cytotoxique et anticorps monoclonaux dirigés contre celle-ci
US5279833A (en) 1990-04-04 1994-01-18 Yale University Liposomal transfection of nucleic acids into animal cells
JP4251406B2 (ja) 1990-04-05 2009-04-08 クレア，ロベルト ウォーク―スルー突然変異誘発
US5512463A (en) 1991-04-26 1996-04-30 Eli Lilly And Company Enzymatic inverse polymerase chain reaction library mutagenesis
US5348867A (en) 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
US5858784A (en) 1991-12-17 1999-01-12 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol- and liposome-based delivery
DE4315127A1 (de) 1993-05-07 1994-11-10 Behringwerke Ag Arzneimittel enthaltend die Untereinheit p40 von Interleukin-12
CA2125763C (fr) 1993-07-02 2007-08-28 Maurice Kent Gately Homodimere p40 de l'interleukine-12
US5573764A (en) 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5928905A (en) 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
ZA95960B (en) 1994-03-14 1995-10-10 Genetics Inst Use of interleukin-12 antagonists in the treatment of autoimmune diseases
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US5514588A (en) 1994-12-13 1996-05-07 Exxon Research And Engineering Company Surfactant-nutrients for bioremediation of hydrocarbon contaminated soils and water
US5766914A (en) 1995-01-26 1998-06-16 Michigan State University Method of producing and purifying enzymes
US5674483A (en) 1995-01-31 1997-10-07 National Jewish Medical And Research Center Treatment for diseases involving inflammation
US5665347A (en) 1995-02-02 1997-09-09 Genetics Institute IL-12 inhibition of B1 cell activity
ATE216590T1 (de) 1995-02-06 2002-05-15 Genetics Inst Arzneimittelformulierungen für il-12
US5891680A (en) 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
US5853714A (en) 1995-03-27 1998-12-29 Genetics Institute, Inc. Method for purification of IL-12
WO1997000321A1 (fr) 1995-06-14 1997-01-03 Commonwealth Scientific And Industrial Research Organisation Modulateurs de la reponse immunitaire et leur utilisation
US6057103A (en) 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
US6004788A (en) 1995-07-18 1999-12-21 Diversa Corporation Enzyme kits and libraries
US6030779A (en) 1995-07-18 2000-02-29 Diversa Corporation Screening for novel bioactivities
US6168919B1 (en) 1996-07-17 2001-01-02 Diversa Corporation Screening methods for enzymes and enzyme kits
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
AU6655396A (en) 1995-08-11 1997-03-12 Novo Nordisk A/S Method for preparing polypeptide variants
US5962258A (en) 1995-08-23 1999-10-05 Diversa Corporation Carboxymethyl cellulase fromthermotoga maritima
US6171820B1 (en) 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
US5814473A (en) 1996-02-09 1998-09-29 Diversa Corporation Transaminases and aminotransferases
US5962283A (en) 1995-12-07 1999-10-05 Diversa Corporation Transminases and amnotransferases
US5830696A (en) 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US20030215798A1 (en) 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
JP2000502568A (ja) 1996-01-10 2000-03-07 ノボ ノルディスク アクティーゼルスカブ 細胞内での突然変異ライブラリーの ｉｎ ｖｉｖｏ製造のための方法
US5942430A (en) 1996-02-16 1999-08-24 Diversa Corporation Esterases
US5958751A (en) 1996-03-08 1999-09-28 Diversa Corporation α-galactosidase
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US5789228A (en) 1996-05-22 1998-08-04 Diversa Corporation Endoglucanases
US5922685A (en) 1996-06-05 1999-07-13 Powderject Vaccines, Inc. IL-12 gene therapy of tumors
US5877001A (en) 1996-06-17 1999-03-02 Diverso Corporation Amidase
US5763239A (en) 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
CA2257863A1 (fr) 1996-06-19 1997-12-24 Diversa Corporation Phosphatases thermostables
US5939300A (en) 1996-07-03 1999-08-17 Diversa Corporation Catalases
CA2266423A1 (fr) 1996-09-27 1998-04-02 Maxygen, Inc. Procedes permettant l'optimisation d'une therapie genique grace a un rearrangement et une selection recursifs de sequences
CA2268265A1 (fr) 1996-09-27 1998-04-02 Maxygen, Inc. Procedes permettant l'optimisation de la therapie genique grace a un rearrangement et une selection recursifs de sequences
ATE295850T1 (de) 1996-12-06 2005-06-15 Diversa Corp Glycosidase-enzyme
CN1208456C (zh) 1996-12-20 2005-06-29 诺维信公司 体内重组
IL130635A0 (en) 1997-01-17 2000-06-01 Maxygen Inc Evolution of whole cells and organisms by recursive sequence recombination
CN1252100A (zh) 1997-02-13 2000-05-03 唐化学原料公司 重组卤代脂族脱卤素酶
WO1998041622A1 (fr) 1997-03-18 1998-09-24 Novo Nordisk A/S Methode de constitution d'une bibliotheque par rearrangement d'adn
CN1249784A (zh) 1997-03-18 2000-04-05 诺沃挪第克公司 一种体外构建dna文库的方法
DE69841674D1 (de) 1997-03-18 2010-07-01 Novozymes As Vermischen von heterologen dns-sequenzen
EP0919241B1 (fr) 1997-05-16 2004-08-04 Toray Industries, Inc. Agent therapeutique, procede de traitement, agent prophylactique et procede prophylactique destines au traitement de maladies immunologiques chez les chiens et les chats
US5948666A (en) 1997-08-06 1999-09-07 Diversa Corporation Isolation and identification of polymerases
US5876997A (en) 1997-08-13 1999-03-02 Diversa Corporation Phytase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999041368A2 (fr) * 1998-02-11 1999-08-19 Maxygen, Inc. Optimisation des proprietes immunomodulatrices des vaccins genetiques

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
A CRAMERI ET AL: "DNA shuffling of a family of genes from diverse species accelerates directed evolution", NATURE,MACMILLAN JOURNALS LTD. LONDON,GB, vol. 391, 1998, pages 288 - 291, XP002159048, ISSN: 0028-0836 *
CHANG CHIA-CHUN J ET AL: "Evolution of a cytokine using DNA family shuffling.", NATURE BIOTECHNOLOGY, vol. 17, no. 8, August 1999 (1999-08-01), pages 793 - 797, XP002165178, ISSN: 1087-0156 *
DATABASE EMBL 19 April 1995 (1995-04-19), FOSS D.L. AND M.P. MURTAUGH: "Sus scrofa interleukin-12 mRNA, complete cds.", XP002165227 *
FOSS DENNIS L ET AL: "Molecular cloning and mRNA expression of porcine interleukin-12.", VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, vol. 57, no. 1-2, 1997, pages 121 - 134, XP000996128, ISSN: 0165-2427 *
PATTEN P A ET AL: "APPLICATIONS OF DNA SHUFFLING TO PHARMACEUTICALS AND VACCINES", CURRENT OPINION IN BIOTECHNOLOGY,LONDON,GB, vol. 8, 1997, pages 724 - 733, XP002916609, ISSN: 0958-1669 *
ZOU J J ET AL: "Structure-function analysis of the p35 subunit of mouse interleukin 12", JOURNAL OF BIOLOGICAL CHEMISTRY,US,AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, vol. 270, no. 11, 17 March 1995 (1995-03-17), pages 5864 - 5871, XP002117289, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
US7115712B1 (en) 2006-10-03
CA2389262A1 (fr) 2001-06-07
US20060264615A1 (en) 2006-11-23
JP2003517305A (ja) 2003-05-27
WO2001040257A2 (fr) 2001-06-07
EP1244689A2 (fr) 2002-10-02

Similar Documents

Publication Publication Date Title
WO2001075087A8 (fr) Variantes de lasubtilisine
WO2000075350A3 (fr) Sequences d'acide nucleique codant des proteines impliquees dans la beta-oxydation des acides gras et procedes d'utilisation
WO2002014358A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2002006457A3 (fr) Genes de lipase
WO2000060060A3 (fr) Polypeptides presentant une activite alcaline alpha-amylase et acides nucleiques les codant
WO2000006738A3 (fr) Acides nucleiques et proteines de streptococcus pneumoniae
WO2003020932A1 (fr) Nouvelles proteines de secretion et adn associe
WO2002008277A3 (fr) Acides nucleiques, vecteurs, cellules hotes, polypeptides et leurs utilisations
WO2001025438A3 (fr) Homologues d'interferons alpha
CA2437201A1 (fr) Procedes et compositions utiles dans la stimulation d'une reponse immunitaire
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
WO2001032882A3 (fr) Acides nucleiques et proteines provenant des streptocoques du groupe b
WO2002046409A3 (fr) Proteines et acides nucleiques les codant
WO2001040257A3 (fr) Polypeptides cytokines et acides nucleiques
WO2000018909A3 (fr) Acides nucleiques et proteines provenant de cenarchaeum symbiosum
WO2002085922A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2001064912A3 (fr) Enzymes de degradation de triazine
WO2000041509A3 (fr) Polypeptides possedant une activite de phosphatase acide et acides nucleiques codant pour ceux-ci
WO2001053453A8 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO2002090500A3 (fr) Nouvelles proteines humaines, polynucleotides codant ces proteines et methodes d'utilisation des proteines
WO2001019870A3 (fr) POLYPEPTIDES SUBUNITAIRES DE CANAL CALCIUM α2δ-2, α2δ-3 OU α2δ-4 SOLUBLES SECRETES, ET ESSAIS DE RECHERCHE SYSTEMATIQUE UTILISANT CES POLYPEPTIDES
WO2002062964A3 (fr) Variants d'amine oxydase ap1
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
WO2002046408A3 (fr) Nouvelles proteines humaines, polynucleotides les codant et procedes d'utilisation
WO2002016578A3 (fr) Nouvelles proteines secretees et procedes d'utilisation de ces dernieres

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2389262

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 19376/01

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 541012

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000982327

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000982327

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000982327

Country of ref document: EP